# NI Holdings, Inc.: financial statements, quarterly

NODK · Nasdaq · CIK 1681206 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/nodk.md) · [Financials](/companies/nodk/financials.md) · [Filings](/companies/nodk/filings.md) · [Insiders](/companies/nodk/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/nodk/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [78.0](/filings/0001174947-24-001226.md) | [78.7 d](/filings/0001174947-26-000305.md) | [74.5](/filings/0001174947-25-000721.md) | [87.8](/filings/0001174947-25-001142.md) | [89.0](/filings/0001174947-25-001356.md) | [73.9 d](/filings/0001174947-26-000305.md) | [71.4](/filings/0001174947-26-000570.md) | [76.1](/filings/0001174947-26-000777.md) | [76.6](/filings/0001174947-25-001356.md) | [61.0 d](/filings/0001174947-26-000305.md) | [59.6](/filings/0001174947-26-000570.md) | [70.2](/filings/0001174947-26-000777.md) |
| Gross profit | $m | [23.3](/filings/0001174947-24-001226.md) | [41.8 d](/filings/0001174947-26-000305.md) | [29.7](/filings/0001174947-25-000721.md) | [15.8](/filings/0001174947-25-001142.md) | [18.2](/filings/0001174947-25-001356.md) | [38.9 d](/filings/0001174947-26-000305.md) | [29.0](/filings/0001174947-26-000570.md) | [6.4](/filings/0001174947-26-000777.md) | [15.7](/filings/0001174947-25-001356.md) | [18.8 d](/filings/0001174947-26-000305.md) | [31.8](/filings/0001174947-26-000570.md) | [16.6](/filings/0001174947-26-000777.md) |
| Income tax | $m | [0.2](/filings/0001174947-24-001226.md) | [0.7 d](/filings/0001174947-26-000305.md) | [1.9](/filings/0001174947-25-000721.md) | [(1.6)](/filings/0001174947-25-001142.md) | [(0.8)](/filings/0001174947-25-001356.md) | [4.0 d](/filings/0001174947-26-000305.md) | [1.3](/filings/0001174947-26-000570.md) | [(3.3)](/filings/0001174947-26-000777.md) | [(0.2)](/filings/0001174947-25-001356.md) | [0.3 d](/filings/0001174947-26-000305.md) | [3.2](/filings/0001174947-26-000570.md) | [0.1](/filings/0001174947-26-000777.md) |
| Net income | $m | [0.2](/filings/0001174947-24-001226.md) | [6.6 d](/filings/0001174947-26-000305.md) | [6.4](/filings/0001174947-25-000721.md) | [(19.6)](/filings/0001174947-25-001142.md) | [(2.7)](/filings/0001174947-25-001356.md) | [9.8 d](/filings/0001174947-26-000305.md) | [6.5](/filings/0001174947-26-000570.md) | [(12.1)](/filings/0001174947-26-000777.md) | [(1.7)](/filings/0001174947-25-001356.md) | [(3.2) d](/filings/0001174947-26-000305.md) | [12.5](/filings/0001174947-26-000570.md) | [0.1](/filings/0001174947-26-000777.md) |
| Diluted EPS | $ per share | [0.01](/filings/0001174947-24-001226.md) | not reported | [0.30](/filings/0001174947-25-000721.md) | [(0.94)](/filings/0001174947-25-001142.md) | [(0.13)](/filings/0001174947-25-001356.md) | not reported | [0.31](/filings/0001174947-26-000570.md) | [(0.57)](/filings/0001174947-26-000777.md) | [(0.08)](/filings/0001174947-25-001356.md) | not reported | [0.60](/filings/0001174947-26-000570.md) | [0.01](/filings/0001174947-26-000777.md) |
| Basic EPS | $ per share | [0.01](/filings/0001174947-24-001226.md) | not reported | [0.31](/filings/0001174947-25-000721.md) | [(0.94)](/filings/0001174947-25-001142.md) | [(0.13)](/filings/0001174947-25-001356.md) | not reported | [0.31](/filings/0001174947-26-000570.md) | [(0.57)](/filings/0001174947-26-000777.md) | [(0.08)](/filings/0001174947-25-001356.md) | not reported | [0.60](/filings/0001174947-26-000570.md) | [0.01](/filings/0001174947-26-000777.md) |

- Revenue: us-gaap:Revenues
- Gross profit: us-gaap:GrossProfit
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [34.5](/filings/0001174947-23-001341.md) | [41.0](/filings/0001174947-25-000304.md) | [68.5](/filings/0001174947-24-000723.md) | [51.4](/filings/0001174947-24-001214.md) | [39.1](/filings/0001174947-24-001226.md) | [50.9](/filings/0001174947-26-000305.md) | [57.2](/filings/0001174947-25-000721.md) | [56.8](/filings/0001174947-25-001142.md) | [24.7](/filings/0001174947-25-001356.md) | [51.7](/filings/0001174947-26-000777.md) | [57.7](/filings/0001174947-26-000570.md) | [51.6](/filings/0001174947-26-000777.md) |
| Total assets | $m | [657](/filings/0001174947-23-001341.md) | [655](/filings/0001174947-25-000304.md) | [675](/filings/0001174947-24-000723.md) | [571](/filings/0001174947-24-001214.md) | [560](/filings/0001174947-24-001226.md) | [527](/filings/0001174947-26-000305.md) | [525](/filings/0001174947-25-000721.md) | [620](/filings/0001174947-25-001142.md) | [544](/filings/0001174947-25-001356.md) | [506](/filings/0001174947-26-000777.md) | [492](/filings/0001174947-26-000570.md) | [543](/filings/0001174947-26-000777.md) |
| Total liabilities | $m | [427](/filings/0001174947-23-001341.md) | [404](/filings/0001174947-25-000304.md) | [419](/filings/0001174947-24-000723.md) | [335](/filings/0001174947-24-001214.md) | [319](/filings/0001174947-24-001226.md) | [282](/filings/0001174947-26-000305.md) | [271](/filings/0001174947-25-000721.md) | [377](/filings/0001174947-25-001142.md) | [300](/filings/0001174947-25-001356.md) | [266](/filings/0001174947-26-000777.md) | [242](/filings/0001174947-26-000570.md) | [294](/filings/0001174947-26-000777.md) |
| Long-term debt | $m | [2.4](/filings/0001174947-23-001341.md) | [2.4](/filings/0001174947-24-000361.md) | [2.4](/filings/0001174947-24-000723.md) | [2.4](/filings/0001174947-24-001214.md) | [2.4](/filings/0001174947-24-001226.md) | [2.4](/filings/0001174947-25-001142.md) | not reported | not reported | [2.4](/filings/0001174947-25-001356.md) | [2.4](/filings/0001174947-26-000305.md) | [2.4](/filings/0001174947-26-000570.md) | [2.4](/filings/0001174947-26-000777.md) |
| Shareholders' equity | $m | [230](/filings/0001174947-24-001226.md) | [250](/filings/0001174947-26-000305.md) | [256](/filings/0001174947-25-001142.md) | [236](/filings/0001174947-25-001356.md) | [241](/filings/0001174947-25-001356.md) | [245](/filings/0001174947-26-000777.md) | [254](/filings/0001174947-26-000777.md) | [243](/filings/0001174947-26-000777.md) | [244](/filings/0001174947-25-001356.md) | [240](/filings/0001174947-26-000777.md) | [250](/filings/0001174947-26-000777.md) | [249](/filings/0001174947-26-000777.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest, us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(10.4) d](/filings/0001174947-24-001226.md) | [41.6 d](/filings/0001174947-26-000305.md) | [16.7](/filings/0001174947-25-000721.md) | [18.1 d](/filings/0001174947-25-001142.md) | [(18.0) d](/filings/0001174947-25-001356.md) | [21.7 d](/filings/0001174947-26-000305.md) | [9.9](/filings/0001174947-26-000570.md) | [6.4 d](/filings/0001174947-26-000777.md) | [(44.8) d](/filings/0001174947-25-001356.md) | [13.2 d](/filings/0001174947-26-000305.md) | [(1.9)](/filings/0001174947-26-000570.md) | [0.9 d](/filings/0001174947-26-000777.md) |
| Capital expenditure | $m | [0.1 d](/filings/0001174947-24-001226.md) | [(0.1) d](/filings/0001174947-26-000305.md) | [0.1](/filings/0001174947-25-000721.md) | [0.6 d](/filings/0001174947-25-001142.md) | [0.1 d](/filings/0001174947-25-001356.md) | [0.2 d](/filings/0001174947-26-000305.md) | [0.0](/filings/0001174947-26-000570.md) | [0.2 d](/filings/0001174947-26-000777.md) | [0.0 d](/filings/0001174947-25-001356.md) | [0.0 d](/filings/0001174947-26-000305.md) | [0.0](/filings/0001174947-26-000570.md) | [0.0 d](/filings/0001174947-26-000777.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [21.3](/filings/0001174947-23-001341.md) | [21.4](/filings/0001174947-24-000723.md) | [21.3](/filings/0001174947-24-001214.md) | [21.2](/filings/0001174947-24-001226.md) | [21.0](/filings/0001174947-25-000721.md) | [21.0](/filings/0001174947-25-001142.md) | [21.0](/filings/0001174947-25-001356.md) | [21.1](/filings/0001174947-26-000570.md) | [21.0](/filings/0001174947-26-000777.md) | [21.0](/filings/0001174947-25-001356.md) | [20.9](/filings/0001174947-26-000570.md) | [20.9](/filings/0001174947-26-000777.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 20,404,723 at 2026-07-31, from the cover of the [10-Q filed 2026-08-07](/filings/0001174947-26-000777.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. No prices; not investment advice.